Ms. Orne succeeds David Fitzhenry as CEO. Mr. Fitzhenry will stay involved in the company as a strategic adviser and member of the board of directors, according to a June 7 Trinity news release.
Trinity provides consulting and commercialization services to life sciences companies.
Ms. Orne has served at Trinity since 2001.
